Bridging science and impact—Repositioning a high-science brand for patient focus.
Our challenge and opportunity
Nurix engaged Waterhouse to sharpen its corporate reputation in order to connect the dots between the company’s foundational role in targeted protein degradation and the ultimate impact of its work: Establishing degrader-based medicines at the forefront of patient care.
Visual identity development, brand and business system
Scientific illustration development
Brand imagery library with new employee photography
Redesigned corporate website
Investor relations and conference materials development
Brand launch support
Nurix’s new brand strategy centers on their formidable advantage in translating scientific excellence into patient impact, highlighting their unparalleled drug discovery engine, data and industry-leading team. Their new tagline: Medicines to Outmatch Disease.
Nurix’s new logo features an “N” icon, visualizing the crucial linker that unites ligases and proteins together, the core mechanism underlying the company’s targeted protein degradation technology.
The brand system includes new employee imagery and business system assets for a cohesive look and feel across all touchpoints.
New scientific illustrations communicate the company’s complex science, multiple platforms and assets as a cohesive visual story.
The company’s website redesign details Nurix’s unique opportunity, science and pipeline with approachable language and graphics.
In preparation for the 2025 J.P. Morgan Healthcare conference, we extended the new brand narrative into investor relations materials.
